Health Care & Life Sciences » Pharmaceuticals | Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
166.44 M
Public Float
104.73 M
Rigel Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.39
Market Cap
$428.01 M
Shares Outstanding
167.19 M
Public Float
159.59 M

Profile

Address
1180 Veterans Boulevard
South San Francisco California 94080
United States
Employees -
Website http://www.rigel.com
Updated 07/08/2019
Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. It focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.

Financials

View All
Created with Highcharts 5.0.14Rigel Pharmaceuticals Inc.Net Income. Fiscal year is January-December. All values USD Thousands.89 02789 02790 90890 90851 46451 46469 21669 21677 99277 99270 48070 480201320142015201620172018025k50k75k100k
Created with Highcharts 5.0.14Rigel Pharmaceuticals Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.7 1507 1508 2508 25028 89528 89520 38320 3834 4844 48444 50944 509201320142015201620172018010k20k30k40k50k

Gary A. Lyons
Chairman
Gregg Anthony Lapointe
Independent Director